[Physiotherapy in chronic obstructive pulmonary disease: oscillatory breathing with flutter VRP1]

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology
• Medical Devices

Background:

• Chronic obstructive pulmonary disease (COPD) often involves mucus hypersecretion, leading to recurrent infections and reduced quality of life.
• Reducing airway secretions is linked to clinical improvement in COPD patients.
• The flutter VRP1 is a novel device designed to aid in clearing bronchial hypersecretion.

Purpose of the Study:

• To evaluate the long-term effectiveness of daily chest physiotherapy with the flutter VRP1 device.
• To assess the impact of VRP1 physiotherapy on patients diagnosed with COPD and sputum hypersecretion.

Main Methods:

• A study involving 20 patients (13 men, 7 women) with COPD and sputum hypersecretion.
• Ten patients received daily physiotherapy with the flutter VRP1, while 10 control patients received sham therapy.
• Measurements included pulmonary function tests, 12-minute walk distance, arterial blood gases, and respiratory rate over a 3-month period.

Main Results:

• The physiotherapy group showed significant improvements in forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and 12-minute walk distance.
• No significant changes were observed in arterial blood gases, maximum voluntary ventilation, or resting respiratory rate in either group.
• The flutter VRP1 group experienced a significant overall improvement in COPD symptoms compared to baseline.

Conclusions:

• Long-term home physiotherapy with the flutter VRP1 device is effective for COPD patients with bronchial hypersecretion.
• The VRP1 demonstrates efficacy in improving airflow, enhancing functional capacity, and alleviating symptoms in COPD.
• Daily use of the flutter VRP1 can be a valuable therapeutic option for managing COPD-related mucus hypersecretion.